Division of Urology, Primary Children's Hospital, Salt Lake City, Utah.
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
J Urol. 2021 Jul;206(1):126-132. doi: 10.1097/JU.0000000000001690. Epub 2021 Mar 8.
Urinary tract infections commonly occur in patients with spina bifida and pose a risk of renal scarring. Routine antibiotic prophylaxis has been utilized in newborns with spina bifida to prevent urinary tract infections. We hypothesized that prophylaxis can safely be withheld in newborns with spina bifida until clinical assessment allows for risk stratification.
Newborns with myelomeningocele at 9 institutions were prospectively enrolled in the UMPIRE study and managed by a standardized protocol with a strict definition of urinary tract infection. Patient data were collected regarding details of reported urinary tract infection, baseline renal ultrasound findings, vesicoureteral reflux, use of clean intermittent catheterization and circumcision status in boys. Risk ratios and corresponding 95% confidence intervals were calculated using log-binomial models.
From February 2015 through August 2019 data were available on 299 newborns (50.5% male). During the first 4 months of life, 48 newborns (16.1%) were treated for urinary tract infection with 23 (7.7%) having positive cultures; however, only 12 (4.0%) met the strict definition of urinary tract infection. Infants with grade 3-4 hydronephrosis had an increased risk of urinary tract infection compared to infants with no hydronephrosis (RR=10.1; 95% CI=2.8, 36.3). Infants on clean intermittent catheterization also had an increased risk of urinary tract infection (RR=3.3; 95% CI=1.0, 10.5).
The incidence of a culture positive, symptomatic urinary tract infection among newborns with spina bifida in the first 4 months of life was low. Patients with high grades of hydronephrosis or those on clean intermittent catheterization had a significantly greater incidence of urinary tract infection. Our findings suggest that routine antibiotic prophylaxis may not be necessary for most newborns with spina bifida.
尿路感染在脊髓裂患者中很常见,并且有导致肾瘢痕的风险。常规抗生素预防已用于脊髓裂新生儿,以预防尿路感染。我们假设,在临床评估允许进行风险分层之前,可以安全地停止脊髓裂新生儿的预防。
9 家机构的患有脊膜脊髓膨出的新生儿前瞻性地参加了 UMPIRE 研究,并按照标准化方案进行管理,该方案对尿路感染有严格的定义。收集了有关报告的尿路感染详细信息、基线肾脏超声检查结果、膀胱输尿管反流、间歇性导尿和男孩包皮环切状态的数据。使用对数二项式模型计算风险比及其相应的 95%置信区间。
从 2015 年 2 月到 2019 年 8 月,299 名新生儿(50.5%为男性)的数据可用。在生命的头 4 个月中,有 48 名新生儿(16.1%)因尿路感染接受治疗,其中 23 名(7.7%)有阳性培养物;然而,只有 12 名(4.0%)符合尿路感染的严格定义。与无肾积水的婴儿相比,等级 3-4 级肾积水的婴儿尿路感染的风险增加(RR=10.1;95%CI=2.8,36.3)。间歇性导尿的婴儿尿路感染的风险也增加(RR=3.3;95%CI=1.0,10.5)。
在生命的前 4 个月中,脊髓裂新生儿中培养阳性、有症状的尿路感染发生率较低。患有高等级肾积水或接受间歇性导尿的患者尿路感染发生率显著更高。我们的发现表明,对于大多数脊髓裂新生儿来说,常规抗生素预防可能不是必需的。